Rocket


News + Filings
Transactions



Booth Bruce

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/07/2023Vigil Neuroscience, Inc. GrantStock Option Grant (Right to Buy)13.9k$10.00$139.3k 06/07/2023
06/06/2023AVROBIO, Inc.AVROGrantStock Option (Right to Buy)17.6k$1.09$19.2k 06/06/2023
01/12/2023Kymera Therapeutics, Inc. SaleCommon Stock77.1k$30.29$2.3MSee footnote01/11/2023
01/12/2023Kymera Therapeutics, Inc. SaleCommon Stock21.6k$30.29$654kSee footnote01/11/2023
01/11/2023Kymera Therapeutics, Inc. SaleCommon Stock21.7k$29.96$649.6kSee footnote01/11/2023
01/11/2023Kymera Therapeutics, Inc. SaleCommon Stock6.1k$29.96$181.9kSee footnote01/11/2023
12/15/2022Kymera Therapeutics, Inc. SaleCommon Stock2.6k$30.00$76.8kSee footnote12/14/2022
12/15/2022Kymera Therapeutics, Inc. SaleCommon Stock717$30.00$21.5kSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock112.8k$30.28$3.4MSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock101.2k$31.44$3.2MSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock54.7k$32.33$1.8MSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock14k$33.34$466.7kSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock13.3k$34.02$453.7kSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock31.6k$30.28$956.4kSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock28.3k$31.44$890.7kSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock15.3k$32.33$495.4kSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock3.9k$33.34$130.7kSee footnote12/14/2022
12/14/2022Kymera Therapeutics, Inc. SaleCommon Stock3.7k$34.02$127kSee footnote12/14/2022
06/28/2022Magenta Therapeutics, Inc.MGTAGrantStock Option (Right to Buy)20k$1.21$24.2k 06/28/2022
06/15/2022Kymera Therapeutics, Inc. GrantStock Option (Right to Buy)12k$14.18$170.2k 06/15/2022
06/09/2022Vigil Neuroscience, Inc. GrantStock Option Grant (Right to Buy)12.2k$3.10$37.7k 06/09/2022
06/08/2022AVROBIO, Inc.AVROGrantStock Option (Right to Buy)17.5k$1.06$18.5k 06/08/2022
03/01/2022Vigil Neuroscience, Inc. GrantStock Option Grant (Right to Buy)7.6k$16.13$122.2k 03/01/2022
01/11/2022Vigil Neuroscience, Inc. ConversionCommon Stock2.8M$0.00$0By Atlas Venture Fund XII, L.P.01/11/2022
01/11/2022Vigil Neuroscience, Inc. ConversionCommon Stock1M$0.00$0By Atlas Venture Opportunity Fund I, L.P.01/11/2022
01/11/2022Vigil Neuroscience, Inc. PurchaseCommon Stock535k$14.00$7.5MBy Atlas Venture Fund XII, L.P.01/11/2022
01/11/2022Vigil Neuroscience, Inc. ConversionSeries A Preferred Stock7.9M$0.00$0By Atlas Venture Fund XII, L.P.01/11/2022
01/11/2022Vigil Neuroscience, Inc. ConversionSeries B Preferred Stock2.9M$0.00$0By Atlas Venture Opportunity Fund I, L.P.01/11/2022
08/11/2021Kymera Therapeutics, Inc. SaleCommon Stock242.1k$61.00$14.8MSee footnote08/11/2021
06/16/2021Kymera Therapeutics, Inc. GrantStock Option (Right to Buy)20.1k$49.10$985.1k 06/16/2021
06/10/2021AVROBIO, Inc.AVROGrantStock Option (Right to Buy)17.4k$9.63$167.9k 06/10/2021
06/01/2021Magenta Therapeutics, Inc.MGTAGrantStock Option (Right to Buy)18.2k$12.91$234.8k 06/01/2021
03/12/2021Kymera Therapeutics, Inc. SaleCommon Stock229.4k$56.50$13MSee footnote03/12/2021
08/25/2020Kymera Therapeutics, Inc. ConversionSeries B Convertible Preferred Stock1.5M$0.00$0See Footnote08/25/2020
08/25/2020Kymera Therapeutics, Inc. ConversionSeries C Convertible Preferred Stock1.8M$0.00$0See Footnote08/25/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy